Analog inhibitors for the pyrophosphate-dependent phosphofructokinase of Entamoeba histolytica and their effect on culture growth.

W. Eubank,R. E. Reeves
DOI: https://doi.org/10.2307/3280916
1982-08-01
Journal of Parasitology
Abstract:Diphosphonate substrate-analogs of inorganic pyrophosphate (PPi) were found to be com- petitive inhibitors for amebal PPi-dependent phosphofructokinase. Analogs of the phosphoryl donor were employed in in vitro growth tests. All appeared to inhibit amebal growth; one was amebistatic at a con- centration of 1 mM. Pyrophosphate analogs are, potentially, therapeutic agents for intestinal amebiasis. A practical reason for the biochemical study of parasite metabolism is to search for an es- sential metabolic step that is catalyzed by an enzyme distinctly different from that of the host, opening the door to a pharmacological attack upon the parasite without harm to the host. The discovery that the human parasite Entamoeba histolytica has a PPi-dependent phosphofructokinase (E.C. 2.7.1.90) (Reeves et al., 1974, 1976) different from the ATP- utilizing enzyme of the human host invited further study of the amebal enzyme. The bio- chemical energy of PPi arising from ana- bolic processes (protein, nucleic acid, and glycogen synthesis) is conserved by phos- phate bond formation in the ameba whereas higher organisms are thought to dispose of this energy by hydrolysis. This report contains our findings on pyrophosphate-analog inhibitors of amebal phosphofructokinase, and our find- ings relative to the inhibition of amebal growth in culture in the presence of the analogs. MATERIALS AND METHODS
What problem does this paper attempt to address?